Completed PHASE4 INTERVENTIONAL 2-arm NCT01378689

Improving Bone Health Among Rheumatoid Arthritis (RA) Patients on Chronic Glucocorticoids

Improving Bone Health Among RA Patients on Chronic Glucocorticoids

Sponsor: Medco Health Services, Inc

Conditions Adverse Effect of Glucocorticoids and Synthetic Analogues Osteoporosis Rheumatoid Arthritis

Updated 5 times since 2017 Last updated: Jan 14, 2013 Started: Sep 30, 2010 Primary completion: Mar 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Adverse Effect of Glucocorticoids and Synthetic Analogues and Osteoporosis and is currently completed. Medco Health Services, Inc leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medco Health Services, Inc
University of Alabama at Birmingham

Data source: University of Alabama at Birmingham

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Birmingham, United States